Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|April 15, 2008
Stereoselective disposition of proton pump inhibitorsTommy Andersson, Lars Weidolf
Rapid Communications in Mass Spectrometry : RCM|June 19, 2007
Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesisTove Johansson, Lars Weidolf, Ulrik Jurva
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2014
Systemic exposure to the metabolites of lesogaberan in humans and animals: a case study of metabolites in safety testingAnn Aurell Holmberg, Anja Ekdahl, Lars Weidolf
Rapid Communications in Mass Spectrometry : RCM|April 15, 2010
P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometryTove Johansson Mali'n, Lars Weidolf, Neal Castagnoli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2004
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activitiesXue-Qing Li, Tommy B Andersson, Marie Ahlström, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: structure elucidation using electrochemistry, mass spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, et al.
Pageof 4